Revvity Stock - weekly outlook after the latest share slide
18.06.2026 - 16:27:39 | ad-hoc-news.de
Edited by ad hoc news Thu Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 14:26 UTC. Details in the imprint.
Revvity Inc. (US76155R1086) comes into Thursday with a recent stock move and a fresh consensus backdrop. MarketBeat shows Revvity shares at $97.72, down 3.46%, with a consensus price target of $107.73.
All news and price data on Revvity stock
Track the latest company updates, market data and background information in one place.
What the market data shows
GuruFocus reported on June 17, 2026, that Revvity shares fell 3.4% and closed at $97.82. The same report put the stock below its GF Value estimate of $120.46.
MarketBeat lists a consensus price target of $107.73. That places the current quote below the street average, without implying any forecast from this article.
Thursday technical backdrop
Thursday’s focus is the chart. The latest quoted level sits near the upper-$90s, while the 52-week range in market data runs from $81.22 to $118.30.
That range gives traders a concrete frame for recent volatility. It also keeps attention on how far the share price still sits from its year-high band.
What the company sells
Revvity builds diagnostics and life sciences tools. Its work spans instruments, assays and software used in research and clinical testing, with informatics also part of the portfolio.
The company’s job listings describe it as a science-based solutions company. That lines up with its mix of laboratory and diagnostic products rather than a single consumer brand.
Where the stock trades today
The shares of Revvity Inc. (US76155R1086) trade on NYSE at $97.72 as of 06/17/2026, 03:59 PM ET.
Key facts on Revvity stock
- Company: Revvity Inc.
- ISIN: US76155R1086
- Ticker: RVTY
- Venue: NYSE
- Price (as of 06/17/2026, 03:59 PM ET): $97.72
- Market cap: $10.91 billion USD (as of 06/2026)
- Sector / Industry: Health Care / Life Sciences Tools and Services
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
